BNP Paribas Financial Markets
LUMO

BNP Paribas Financial Markets’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

BNP Paribas Financial Markets’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29
Closed -$663 – 4502
2019
Q4 		$663 Sell
29
-392
-93% -$5.59K ﹤0.01% 4241
2019
Q3 		$6.02K Sell
421
-12
-3% -$176 ﹤0.01% 4245
2019
Q2 		$5.77K Sell
433
-285
-40% -$4.3K ﹤0.01% 4221
2019
Q1 		$12.5K Buy
718
+557
+346% +$8.3K ﹤0.01% 3998
2018
Q4 		$2.21K Buy
161
+79
+96% +$1.39K ﹤0.01% 3783
2018
Q3 		$1.77K Hold
82
– – ﹤0.01% 4278
2018
Q2 		$3.52K Sell
82
-569
-87% -$26.1K ﹤0.01% 4173
2018
Q1 		$42.5K Sell
651
-1
-0.2% -$71 ﹤0.01% 3645
2017
Q4 		$47.6K Buy
652
+419
+180% +$34.7K ﹤0.01% 3690
2017
Q3 		$21.3K Sell
233
-17
-7% -$1.3K ﹤0.01% 3564
2017
Q2 		$16.5K Buy
250
+241
+2,678% +$29.8K ﹤0.01% 3759
2017
Q1 		$1.9K Sell
9
-118
-93% -$16.9K ﹤0.01% 3549
2016
Q4 		$11.8K Sell
127
-118
-48% -$13.3K ﹤0.01% 3381
2016
Q3 		$33.1K Buy
245
+84
+52% +$8.34K ﹤0.01% 2623
2016
Q2 		$16.3K Buy
161
+148
+1,138% +$18.3K ﹤0.01% 2678
2016
Q1 		$2.09K Sell
13
-618
-98% -$125K ﹤0.01% 2404
2015
Q4 		$207K Buy
631
+107
+20% +$34.8K ﹤0.01% 1908
2015
Q3 		$169K Buy
524
+332
+173% +$146K ﹤0.01% 2073
2015
Q2 		$76.6K Buy
192
+141
+276% +$59.9K ﹤0.01% 2233
2015
Q1 		$25.3K Buy
+51
New +$19.8K ﹤0.01% 2257
2014
Q4 		– Sell
-144
Closed -$27.7K – 3322
2014
Q3 		$27.7K Buy
144
+119
+476% +$26.2K ﹤0.01% 2943
2014
Q2 		$6.08K Buy
+25
New +$5.08K ﹤0.01% 2495
2014
Q1 		– Sell
-24
Closed -$7.34K – 3330
2013
Q4 		$4.78K Buy
+24
New +$4.27K ﹤0.01% 3126

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BNP Paribas Financial Markets's LUMO Position: Q1 2020 in Review

BNP Paribas Financial Markets sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 29 shares — an estimated $663 sold.

BNP Paribas Financial Markets first reported a position in LUMO in Q4 2013 and held it in 23 quarters. The position peaked at $207K in Q4 2015. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • BNP Paribas Financial Markets reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 29 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $663.
  • BNP Paribas Financial Markets first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 23 quarters.
  • BNP Paribas Financial Markets's Lumos Pharma, Inc. Common Stock position peaked at $207K in Q4 2015.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.